Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Approaching diversity in anatomical education through metaverse.

Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft·2026
Same author

Development of an <i>in vitro</i> platform for epithelial-stromal interactions: A basement membrane-containing scaffold from decellularized porcine bladders.

Matrix biology plus·2025
Same author

The secretome from human-derived mesenchymal stem cells augments the activity of antitumor plant extracts in vitro.

Histochemistry and cell biology·2024
Same author

Induced selectivity in the photochemistry of estrone derivatives in sustainable and micellar environment: preparative and mechanistic studies.

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2021
Same author

Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia.

Revista portuguesa de pneumologia·2015

Related Experiment Video

Updated: Jun 22, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Switch therapy in community-acquired pneumonia

J A Ramirez1

  • 1Division of Infectious Diseases, University of Louisville School of Medicine, KY 40292, USA.

Diagnostic Microbiology and Infectious Disease
|May 1, 1995
PubMed
Summary

Switching intravenous antibiotics to oral medication for community-acquired pneumonia is safe and effective. This approach significantly reduces hospital costs and patient risks, achieving high clinical cure rates.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Hospital Administration

Background:

  • Community-acquired pneumonia (CAP) necessitates intravenous antimicrobial therapy for hospitalized patients.
  • Early clinical improvement is a key indicator for transitioning to oral antibiotics.
  • Current practices often prolong intravenous therapy beyond clinical necessity.

Purpose of the Study:

  • To evaluate the safety and efficacy of switching from intravenous to oral antimicrobials in hospitalized CAP patients.
  • To assess the impact of switch therapy on clinical cure rates and hospital cost savings.
  • To identify criteria for safe and timely transition to oral therapy.

Main Methods:

  • Prospective clinical studies involving over 150 hospitalized CAP patients treated with switch therapy.

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Experiment Videos

Last Updated: Jun 22, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

  • Patients met specific criteria: improving respiratory symptoms, afebrile for ≥8 hours, normalizing white blood cell count, and normal gastrointestinal absorption.
  • For unknown etiologies, oral antibiotics matched the intravenous empiric spectrum.

    • Main Results:

    • Achieved a clinical cure rate of 99.3% in patients treated with switch therapy.
    • Reported hospital savings of $114,080 in 1994 for 80 CAP patients treated with switch therapy.
    • Switch therapy demonstrated equivalent clinical cure rates compared to conventional therapy.

    Conclusions:

    • Switch therapy from intravenous to oral antimicrobials is a safe, effective, and cost-saving strategy for community-acquired pneumonia.
    • Early transition to oral antibiotics reduces risks of intravenous line complications and nosocomial infections.
    • Switch therapy represents a primary option for healthcare cost containment in antibiotic management.